These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21560181)

  • 1. Non-human viruses developed as therapeutic agent for use in humans.
    Koppers-Lalic D; Hoeben RC
    Rev Med Virol; 2011 Jul; 21(4):227-39. PubMed ID: 21560181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Assessment of the Health Risk for Livestock When Animal Viruses Are Applied in Human Oncolytic Therapy: A Case Study for Seneca Valley Virus.
    Schijven J; Brizee S; Teunis P; de Vos C; Eblé P; Rutjes S
    Risk Anal; 2019 May; 39(5):982-991. PubMed ID: 30395685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory aspects of oncolytic virus products.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic virotherapy.
    Sze DY; Reid TR; Rose SC
    J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.
    Reddy PS; Burroughs KD; Hales LM; Ganesh S; Jones BH; Idamakanti N; Hay C; Li SS; Skele KL; Vasko AJ; Yang J; Watkins DN; Rudin CM; Hallenbeck PL
    J Natl Cancer Inst; 2007 Nov; 99(21):1623-33. PubMed ID: 17971529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosafety of non-human therapeutic viruses in clinical gene therapy.
    Hoeben RC; Louz D; Koppers-Lalic D
    Curr Gene Ther; 2013 Dec; 13(6):492-9. PubMed ID: 24397530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viruses: From bench to bedside with a focus on safety.
    Buijs PR; Verhagen JH; van Eijck CH; van den Hoogen BG
    Hum Vaccin Immunother; 2015; 11(7):1573-84. PubMed ID: 25996182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials.
    Matsuda T; Karube H; Aruga A
    Ther Innov Regul Sci; 2018 Jul; 52(4):430-437. PubMed ID: 29714547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.
    Velazquez-Salinas L; Naik S; Pauszek SJ; Peng KW; Russell SJ; Rodriguez LL
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):108-115. PubMed ID: 28514874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for Clinical Translation of MG1 Maraba Virus.
    Breitbach CJ
    Methods Mol Biol; 2020; 2058():285-293. PubMed ID: 31486046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Application of Oncolytic Viruses: A Systematic Review.
    Cook M; Chauhan A
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.
    Liu H; Luo H
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measles virus: a future therapeutic agent in oncology?].
    Touchefeu Y; Schick U; Harrington KJ
    Med Sci (Paris); 2012 Apr; 28(4):388-94. PubMed ID: 22549866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future prospects for oncolytic therapy.
    McCormick F
    Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic virus therapy: A new era of cancer treatment at dawn.
    Fukuhara H; Ino Y; Todo T
    Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches.
    Goradel NH; Mohajel N; Malekshahi ZV; Jahangiri S; Najafi M; Farhood B; Mortezaee K; Negahdari B; Arashkia A
    J Cell Physiol; 2019 Jun; 234(6):8636-8646. PubMed ID: 30515798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.